Abstract
The chaperone glucose-regulated protein 94 (GRP94) has long been used to augment peptide presentation to T cells. This chaperone binds antigenic peptides, binds to receptors on professional antigen-presenting cells (APCs), activates these cells and after internalization, transfers the peptides to MHC class I for activation of T cells. Here we show that all these activities reside within amino acids 1-355 of GRP94. This small fragment is sufficient to bind peptides, to bind and be taken up by the receptors CD91 and scavenger receptor type A on either dendritic cells or macrophages. The minimal construct can augment peptide presentation in culture and induce antigen-specific CTL in naive mice only because it loads APCs with the relevant peptide. Thus, the sequence 1-355 is the immunologically sufficient module of GRP94 and we propose that this 'mini-chaperone' can be used in immunotherapy of tumors and vaccine development. © 2006 Oxford University Press.
Author supplied keywords
Cite
CITATION STYLE
Biswas, C., Sriram, U., Ciric, B., Ostrovsky, O., Gallucci, S., & Argon, Y. (2006). The N-terminal fragment of GRP94 is sufficient for peptide presentation via professional antigen-presenting cells. International Immunology, 18(7), 1147–1157. https://doi.org/10.1093/intimm/dxl049
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.